Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.
Pölönen P, Di Giacomo D, Seffernick AE, Elsayed A, Kimura S, Benini F, Montefiori LE, Wood BL, Xu J, Chen C, Cheng Z, Newman H, Myers J, Iacobucci I, Li E, Sussman J, Hedges D, Hui Y, Diorio C, Uppuluri L, Frank D, Fan Y, Chang Y, Meshinchi S, Ries R, Shraim R, Li A, Bernt KM, Devidas M, Winter SS, Dunsmore KP, Inaba H, Carroll WL, Ramirez NC, Phillips AH, Kriwacki RW, Yang JJ, Vincent TL, Zhao Y, Ghate PS, Wang J, Reilly C, Zhou X, Sanders MA, Takita J, Kato M, Takasugi N, Chang BH, Press RD, Loh M, Rampersaud E, Raetz E, Hunger SP, Tan K, Chang TC, Wu G, Pounds SB, Mullighan CG, Teachey DT. Pölönen P, et al. Among authors: kato m. Nature. 2024 Aug;632(8027):1082-1091. doi: 10.1038/s41586-024-07807-0. Epub 2024 Aug 14. Nature. 2024. PMID: 39143224
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.
Schmiegelow K, Attarbaschi A, Barzilai S, Escherich G, Frandsen TL, Halsey C, Hough R, Jeha S, Kato M, Liang DC, Mikkelsen TS, Möricke A, Niinimäki R, Piette C, Putti MC, Raetz E, Silverman LB, Skinner R, Tuckuviene R, van der Sluis I, Zapotocka E; Ponte di Legno toxicity working group. Schmiegelow K, et al. Among authors: kato m. Lancet Oncol. 2016 Jun;17(6):e231-e239. doi: 10.1016/S1470-2045(16)30035-3. Lancet Oncol. 2016. PMID: 27299279 Free article. Review.
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia.
Andrés-Jensen L, Attarbaschi A, Bardi E, Barzilai-Birenboim S, Bhojwani D, Hagleitner MM, Halsey C, Harila-Saari A, van Litsenburg RRL, Hudson MM, Jeha S, Kato M, Kremer L, Mlynarski W, Möricke A, Pieters R, Piette C, Raetz E, Ronceray L, Toro C, Grazia Valsecchi M, Vrooman LM, Weinreb S, Winick N, Schmiegelow K; Ponte di Legno Severe Toxicity Working Group. Andrés-Jensen L, et al. Among authors: kato m. Lancet Haematol. 2021 Jul;8(7):e513-e523. doi: 10.1016/S2352-3026(21)00136-8. Lancet Haematol. 2021. PMID: 34171282 Free article. Review.
Challenges to Widespread Use of Fertility Preservation Facilities for Pediatric Cancer Patients in Japan.
Maezawa T, Suzuki N, Takeuchi H, Nishioka M, Hidaka M, Manabe A, Koga Y, Kawaguchi H, Sasahara Y, Tachibana M, Iwamoto S, Horie A, Hiramatsu H, Kato M, Harada M, Yuza Y, Hirayama M, Takita J, Ikeda T, Matsumoto K. Maezawa T, et al. Among authors: kato m. J Adolesc Young Adult Oncol. 2024 Feb;13(1):197-202. doi: 10.1089/jayao.2023.0059. Epub 2023 Aug 3. J Adolesc Young Adult Oncol. 2024. PMID: 37535825
A case of fetal-onset type 3 familial hemophagocytic lymphohistiocytosis surviving without severe complications after early diagnosis and treatment.
Matsumoto T, Fukushima H, Fujiyama S, Nagatomo K, Hosaka S, Suzuki R, Yamaki Y, Kanai Y, Shibata H, Yasumi T, Isshiki K, Kato M, Miyazono Y, Takada H. Matsumoto T, et al. Among authors: kato m. Pediatr Blood Cancer. 2021 Jul;68(7):e29016. doi: 10.1002/pbc.29016. Epub 2021 Mar 26. Pediatr Blood Cancer. 2021. PMID: 33769695 No abstract available.
[To submit, or not to submit].
Kato M. Kato M. Rinsho Ketsueki. 2019;60(9):1396-1400. doi: 10.11406/rinketsu.60.1396. Rinsho Ketsueki. 2019. PMID: 31597869 Japanese.
Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
Amano H, Uchida H, Harada K, Narita A, Fumino S, Yamada Y, Kumano S, Abe M, Ishigaki T, Sakairi M, Shirota C, Tainaka T, Sumida W, Yokota K, Makita S, Karakawa S, Mitani Y, Matsumoto S, Tomioka Y, Muramatsu H, Nishio N, Osawa T, Taguri M, Koh K, Tajiri T, Kato M, Matsumoto K, Takahashi Y, Hinoki A. Amano H, et al. Among authors: kato m. Cancer Sci. 2024 May;115(5):1634-1645. doi: 10.1111/cas.16116. Epub 2024 Feb 27. Cancer Sci. 2024. PMID: 38411285 Free PMC article.
Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation Strategy in Muscle-Invasive Bladder Cancer.
Onishi T, Shibahara T, Sekito S, Kato M, Sugino Y, Inoue T. Onishi T, et al. Among authors: kato m. Clin Genitourin Cancer. 2024 Dec 10;23(2):102290. doi: 10.1016/j.clgc.2024.102290. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39798182
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study.
Ogita C, Noguchi K, Takeuchi J, Azuma N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Kawahito Y, Ito-Ihara T, Kida T, Yajima N, Kawaguchi T, Matsui K. Ogita C, et al. Among authors: kato m. Immunol Med. 2025 Jan 11:1-8. doi: 10.1080/25785826.2024.2448912. Online ahead of print. Immunol Med. 2025. PMID: 39797708
9,337 results